WuXi Biologics boosts issued shares after option exercises

On November 12, 2025, WuXi Biologics reported an increase of 7,500,000 ordinary shares, raising its total issued shares from 4,083,627,254 to 4,091,127,254. This change represents a 0.18366% increase from the existing number of issued shares before the event.

The new shares were issued as a result of the exercise of share options under the company's Pre-IPO Share Option Scheme, adopted on January 5, 2016, and amended on August 10, 2016. The issue price per share for these options was HK$1.29.

The company confirmed that all necessary legal and regulatory requirements were met for this issuance, including authorization by the board of directors and compliance with applicable listing rules. All money due to the issuer in respect of the shares has been received, and the newly issued securities are identical in all respects to existing shares.